UTI AMC shareholders approve Narayan Subramaniam Ayypankav as independent director

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • UTI AMC shareholders approved Narayan Subramaniam Ayypankav as Non-Executive Independent Director via postal ballot
  • Special resolution passed with 99.99% votes in favor out of 113,063,575 votes polled
  • Institutional investors voted 100% in favor, while non-institutional public shareholders had 1.32% dissent
  • E-voting period concluded on October 7, 2026, with results declared on October 8, 2026
powered bylight_fuzz_icon
53000040

*this image is generated using AI for illustrative purposes only.

UTI Asset Management Company Limited announced that its shareholders have approved the appointment of Narayan Subramaniam Ayypankav as a Non-Executive Independent Director. The resolution was passed via postal ballot conducted through remote e-voting, securing the requisite majority under the Companies Act, 2013.

The e-voting period ran from September 8, 2026, to October 7, 2026. The scrutinizer’s report, submitted by Vishal N. Manseta, confirmed that the special resolution received overwhelming support from public shareholders. Institutional investors voted unanimously in favor, while non-institutional public shareholders showed minor dissent.

Voting Results Breakdown

The following table details the voting outcomes across shareholder categories for the special resolution regarding Mr. Ayypankav appointment (DIN: 00007404).

Category Shares Held Votes Polled In Favor Against % In Favor
Promoter and Promoter Group 0 0 0 0 0.00%
Public - Institutions 113,718,373 112,645,565 112,645,565 0 100.00%
Public - Non-Institutions 14,820,655 418,010 412,470 5,540 98.67%
Total 128,539,028 113,063,575 113,058,035 5,540 99.99%

What the Numbers Show

A clear divergence exists in voting behavior between institutional and non-institutional public shareholders. While institutional investors cast 112,645,565 votes entirely in favor, non-institutional shareholders recorded 5,540 votes against the resolution. This represents a 1.32% dissent rate among retail or individual public shareholders who participated, compared to zero dissent from institutions. The total turnout among public shareholders was approximately 87.96% of their combined holding, indicating strong engagement on this governance matter.

Procedural Details

The appointment was sought through a special resolution, requiring a higher threshold of approval than ordinary resolutions. The notice for the postal ballot was sent electronically on September 7, 2026, to members registered as of the cut-off date, September 4, 2026. KFin Technologies Limited served as the e-voting service provider.

Mr. Ayypankav will serve as an Independent Director not liable to retire by rotation. The results were declared pursuant to Regulation 44(3) of the SEBI Listing Regulations, and the scrutinizer’s report is available on the company’s website.

Historical Stock Returns for UTI AMC

1 Day5 Days1 Month6 Months1 Year5 Years
-1.25%-1.32%-3.68%-8.66%-36.10%-19.79%

How will Narayan Subramaniam Ayyankav's professional background influence UTI AMC's strategic direction in the evolving asset management landscape?

What specific governance reforms or board restructuring initiatives might this appointment signal for UTI AMC's future compliance posture?

Could the minor dissent from retail shareholders indicate underlying concerns about UTI AMC's recent performance or management transparency?

UTI AMC schedules Q2FY27 earnings call for October 27 at 4 pm

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • UTI AMC hosts earnings call on October 27, 2026, at 4:00 pm IST
  • Call covers financial performance for Q2FY27 and H1FY27
  • MD & CEO Vetri Subramaniam and CFO Vinay Lakhotia will participate
  • Universal access number is +91 22 6280 1102
powered bylight_fuzz_icon
52744734

*this image is generated using AI for illustrative purposes only.

UTI Asset Management Company Limited has scheduled its earnings conference call to discuss the financial performance for the quarter and half year ended September 30, 2026. The event is set for Tuesday, October 27, 2026, at 4:00 pm IST.

Conference Call Details

The management will present the results of the company's operations for the second quarter of fiscal year 2027. Investors and analysts can access the call via universal numbers or international toll-free lines provided in the official intimation.

Detail Information
Date October 27, 2026
Time 4:00 pm IST
Period Covered Q2FY27 and H1FY27
Universal Access Number +91 22 6280 1102, +91 22 7115 8003

Management Participation

Key members of the UTI AMC leadership team will be available to address queries regarding the company's recent financial results and strategic direction.

  • Vetri Subramaniam, Managing Director & CEO
  • Vinay Lakhotia, Chief Financial Officer & Head - Corporate Strategy
  • Sandeep Samsi, Head - Investor Experience and Corporate Affairs

Access Instructions

Participants may join using the DiamondPassâ„¢ registration link for immediate access without operator assistance. International toll-free numbers are available for callers from the USA, UK, Singapore, Australia, and other major markets. For further inquiries, stakeholders may contact Adfactors PR Pvt. Ltd., the company's investor relations firm.

Historical Stock Returns for UTI AMC

1 Day5 Days1 Month6 Months1 Year5 Years
-1.25%-1.32%-3.68%-8.66%-36.10%-19.79%

How might UTI AMC's Q2FY27 AUM growth trajectory compare to its major competitors in the Indian mutual fund industry?

What strategic initiatives is management expected to highlight to address potential market volatility impacting the half-year performance?

Will the upcoming earnings call reveal new product launches or digital transformation investments aimed at expanding retail investor penetration?

More News on UTI AMC

1 Year Returns:-36.10%